Biovac Is A South African Company Founded In 2003 Through A Public Private Partnership Aimed At Revitalizing The Country S Vaccine Manufacturing Capabilitiesthe Company Focuses On Developing A Fully Integrated Vaccine Manufacturing Capacity While Building Local Biotechnology Skills And Utilizing Advanced Manufacturing Technologies Through Global Partnerships Biovac Offers A Variety Of Services In Vaccine Manufacturingincluding Packaging And Distributionfill And Finish Operationsand Technology Transfer And Developmentthe Company Manufactures Several Vaccinessuch As A Hexavalent Vaccine Licensed From Sanofi And A Multivalent Pneumococcal Conjugate Vaccine In Collaboration With Pfizerbiovac Supplies A Comprehensive Range Of Vaccines To Support Public Health Initiatives In South Africa And Neighboring Countries
